Medical network - on January 4, 2017, January 3 night, love announcement of ophthalmology, a wholly owned subsidiary of the United States love's proposed $18 million acquisition of AW Healthcare Management, LLC, a 75% stake in the company including Wang Vision eye center all of the assets, business.
"This acquisition is love eye implementation of international strategy and an important measure." Love, ophthalmology chairman Chen Bang said that buying a famous high-quality goods eye center, a company depth understanding American market and high-end medical service mode of operation of ophthalmology, implement company diversified service mode and perfect service system upgrade.
Chen Bang, on the other hand, contend that the move will enrich and expand the company's global outstanding team of experts, corporate globalization to promote academic research work, for the company to build a higher level of world-class scientific research, talent, technology innovation platform, further enhance the company's core competitiveness and international influence.
In addition, the eye center has good prospects for development, through to the target company resources integration, to improve the company's assets returns and shareholder value.
Announcement, according to Wang Vision eye center by the international famous refractive surgery and corneal disease treatment expert Dr. Ming Wang founded in April 2002, is a world influence of eye center, has the world's cutting-edge technology of refractive surgery, and has comprehensive corneal imaging technology. Eye center for north American and global high-end customers, has been service from more than 55 countries and across the United States more than 40 patients.
Dr. Ming Wang is the ophthalmic authority, a former U.S. food and drug administration (FDA) excimer laser, new technology and equipment for examination and approval committee in the world has more than 55000 cases of eye laser surgery success experience, has a number of American biotechnology patents in the field of visual recovery, leading the world's first artificial cornea laser implantation, the first matrix ring implant surgery in the treatment of keratoconus, has eight international technology patent.
Love, ophthalmology chairman secretary Wu Shijun, said the United States as the world's health one of the most developed countries, has a mature, advanced medical service concept, and the cutting edge of technology system. Through this transaction, the company acquired leading eye institutions in the United States, to cut into the north American medical market rapidly, at the same time, the move will internationalization development for the company to further accumulate experience, and speed up the overseas layout to lay a solid foundation for the future. |
